findmyKOL
Clinical trialNCT07638332Not, yet, recruitingPhase 1/PHASE2Interventional

Evaluation of the Safety and Efficacy of LB-DTK-BKV in Patients With BK Virus-Associated Hemorrhagic Cystitis Following Allogeneic Hematopoietic Stem Cell Transplantation.

SponsorLucasBioEnrollment42Hemorrhagic Cystitis
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Eun Sun Yoo, MD-PhD

    Department of Pediatric Hematology Oncology, Ewha Womans University Seoul Hospital

    Principal Investigator
  • Ho-joon Im, MD-PhD

    Department of Pediatric Hematology & Oncology, Asan Medical Center

    Principal Investigator
  • Hoon Kook, MD-PhD

    Department of Pediatric Hematology & Oncology, Chonnam National University Hwasun Hospital

    Principal Investigator
  • Hyeon Jin Park, MD-PhD

    National Cancer Center, Korea

    Principal Investigator
  • Hyoung Jin Kang, MD-PhD

    Department of Pediatric Hematology-Oncology, Seoul National University Hospital

    Principal Investigator
  • Jae-Cheol Jo, MD-PhD

    Department of Hematology, Ulsan University Hospital

    Principal Investigator
  • Joonho Moon, MD-PhD

    Department of Hematology-Oncology, Kyungpook National University Chilgok Hospital

    Principal Investigator
  • Seung Min Hahn, MD-PhD

    Department of Pediatric Hematology & Oncology, Severance Hospital

    Principal Investigator
  • Ye-jin Kim, MD-PhD

    Department of Pediatrics, Samsung Seoul Hospital

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

South Korea
  • Asan Medical Center

    Seoul, Seoul, South Korea

    Ho-joon Im, MD-PhD
  • Samsung Seoul Hospital

    Seoul, Seoul, South Korea

    Ye-jin Kim, MD-PhD
  • Seoul National University Hospital

    Seoul, Seoul, South Korea

    Hyoung Jin Kang, MD-PhD
  • Severance Hospital

    Seoul, Seoul, South Korea

  • Kyungpook National University Chilgok Hospital

    Daegu, South Korea

    Joonho Moon, MD-PhD
  • National Cancer Center Korea

    Goyang-si, South Korea

    Hyeon Jin Park, MD-PhD
  • Chonnam National University Hwasun Hospital

    Hwasun, South Korea

    Hoon Kook, MD-PhD
  • Ewha Womans University Seoul Hospital

    Seoul, South Korea

    Eun Sun Yoo, MD-PhD
  • Ulsan University Hospital

    Ulsan, South Korea

    Jae-Cheol Jo, MD-PhD

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
1 Sept 2026
Primary completion
1 Mar 2028
Completion
1 Mar 2028
Last update posted
17 Jun 2026
Registered enrollment
42
Registry id
NCT07638332

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.